About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Back to clinical trial search

COMPLETEDPhase 1/2NCT02106260

First-in-Human Study of CLS003 ICVT in Subjects With Cutaneous Warts

This phase I/IIa study has an open-label, First-in-Human (FIH), single center design to assess the safety, pharmacokinetics (PK) and pharmacodynamics (PD) of multiple doses of topically applied CLS003...

Lead sponsor: Maruho Co., Ltd.•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Clareo turns complex medical information into clear understanding you can use.

Bring this clarity to your next appointment.

Keep all your medical notes and next steps in one place.

Sponsors

Lead Sponsor

Maruho Co., Ltd.

Age

18 - 65 years

Sex

ALL

Healthy Volunteers

Yes

Inclusion Criteria

•Healthy subjects (male, non-pregnant female), 18 to 65 years of age, inclusive.
•Body mass index (BMI) between 18 and 30kg/m2, inclusive
•Fitzpatrick skin type I-II-III-IV
•At least 4 cutaneous warts on the hands, separated by at least 1cm of skin

Exclusion Criteria

•For women, a positive pregnancy test and/or nursing at screening
•A positive test for drugs of abuse at screening
•History of alcohol or illicit drug abuse
•Positive test results for Hepatitis B, Hepatitis C or HIV
•Have used salicylic acid or any other over-the-counter- wart-removing product in the treatment area within 30 days prior to enrollment
•Have received cryotherapy in the treatment area within 60 days prior to enrollment
•Have required systemic intake of immunosuppressive or immunomodulatory medication (including oral or parenteral corticosteroids) with 30 days prior to enrollment or during the course of the study.

Related studies

Enrolling By InvitationEARLY Phase 1

Role of Intralesional Combined Injection of Furosemide and Digoxin in Cutaneous Warts at Tertiary Care Hospital in Karachi.

NCT06821594 · Cutaneous Warts

Not Yet RecruitingEARLY Phase 1

Evaluation of the Efficacy of Cryotherapy Combined With Intralesional Hepatitis B Virus Vaccine Versus Either Therapy in the Treatment of Multiple Cutaneous Warts :a Comparative Study

NCT05902624 · Cutaneous Warts

COMPLETEDPhase 2

Intralesional Bleomycin Versus Cryotherapy for Treatment of Cutaneous Warts

NCT05023408 · Cutaneous Warts

COMPLETEDPhase 2/3

Oral Zinc Gluconate as Treatment for Recalcitrant Cutaneous Warts: A Randomized, Double-blind, Placebo-controlled Trial

NCT01783353 · Recalcitrant Cutaneous Warts

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: May 23, 2014Terms

Trial snapshot

StatusCOMPLETED

PhasePHASE1/PHASE2

Enrollment12

Start dateMar 2014

Last updatedMay 23, 2014

Condition

Cutaneous Warts

Locations shown

Centre for Human Drug Research

Zernikedreef 8

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: May 23, 2014Data synced to Clareo: May 10, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions